Baur B, Baumgartner E R
Metabolic Unit, University Children's Hospital, 4005, Basel, Switzerland.
Brain Res. 2000 Mar 10;858(2):348-55. doi: 10.1016/s0006-8993(00)01944-2.
The uptake of biotin and the closely related biocytin was characterized in primary cultures of calf brain microvessel endothelial (CBME) cells. Biotin uptake was found to be Na(+)-gradient dependent and independent of changes in the membrane potential. Concentration dependence revealed a single saturation mechanism with a K(m) of 47 microM and a V(max) of 101 pmol/min/mg. Inhibition studies demonstrated dependence on metabolic energy and the necessity for a free carboxyl group for transport activity. The anticonvulsants primidone and carbamazepine had no inhibitory effect. Biotin uptake into CBME cells is a secondary active, electroneutral, saturable and specific process. Biocytin which accumulates in biotinidase deficiency, a human congenital disorder, did not inhibit biotin uptake and was not transported into these cells. The presence of human serum with normal biotinidase activity significantly reduced biotin uptake by about 50%. Further, added biocytin was hydrolyzed to biotin, which accumulated intracellularly but to a lesser extent than added free biotin. Biotin uptake after addition of plasma of biotinidase-deficient patients was not different from that in the presence of normal serum. These results indicate that the absence of biotinidase activity in serum does not reduce blood-brain barrier transport of biotin.
在小牛脑微血管内皮(CBME)细胞的原代培养物中,对生物素及其密切相关的生物胞素的摄取进行了表征。发现生物素摄取依赖于Na(+)梯度,且与膜电位变化无关。浓度依赖性显示出单一的饱和机制,K(m)为47 microM,V(max)为101 pmol/min/mg。抑制研究表明其依赖于代谢能量以及转运活性需要一个游离羧基。抗惊厥药扑米酮和卡马西平没有抑制作用。生物素摄取到CBME细胞中是一个继发性主动、电中性、可饱和且特异的过程。在生物素酶缺乏症(一种人类先天性疾病)中积累的生物胞素不抑制生物素摄取,也不被转运到这些细胞中。具有正常生物素酶活性的人血清的存在显著降低了约50%的生物素摄取。此外,添加的生物胞素被水解为生物素,生物素在细胞内积累,但程度低于添加的游离生物素。添加生物素酶缺乏症患者的血浆后,生物素摄取与正常血清存在时没有差异。这些结果表明血清中缺乏生物素酶活性不会降低生物素的血脑屏障转运。